Pituitary adenylate cyclase-activating polypeptide inhibits cutaneous immune function

European Journal of Immunology

Volumn 33, Issue 11, 2003, Pages 3070-3079

  Kodali, Sreedevi ^a   Friedman, Ilyse ^a   Ding, Wanhong ^a   Seiffert, Kristina ^a   Wagner, John A ^a   Granstein, Richard D ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Antigen presentation; Langerhans cells; Neuropeptides; Skin

Indexed keywords

ADRENALIN; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CD86 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MESSENGER RNA;

ADRENALIN RELEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; CELL FUNCTION; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; DOWN REGULATION; EPIDERMIS CELL; FEMALE; GENE EXPRESSION; HYBRIDOMA; IMMUNE SYSTEM; IMMUNOREGULATION; IN VITRO STUDY; INJECTION SITE; LANGERHANS CELL; LYMPHOCYTE CLONE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PURIFICATION; SKIN FUNCTION; SKIN NERVE; SKIN SENSITIZATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD86; DERMATITIS, CONTACT; HYBRIDOMAS; INTERLEUKIN-10; LANGERHANS CELLS; MEMBRANE GLYCOPROTEINS; MICE; NEUROPEPTIDES; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; SKIN; T-LYMPHOCYTES;

EID: 0242559059     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200324085     Document Type: Article

References (56)

1. Schmitt, D., Immune functions of the human skin. Models of in vitro studies using Langerhans cells. Cell Biol. Toxicol. 1999. 15: 41-45.
2. Hogan, A. D. and Burks, A. W., Epidermal Langerhans' cells and their function in the skin immune system. Ann. Allergy Asthma Immunol. 1995. 75: 5-10; quiz 10-12.
3. Hosoi, J., Murphy, G. F., Egan, C. L. Lerner, E. A., Grabbe, S., Asahina, A. and Granstein, R. D., Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 1993. 363: 159-163.
4. Torii, H., Hosoi, J., Beissert, S., Xu, S., Fox, F. E., Asahina, A., Takashima, A., Rook, A. H. and Granstein, R. D., Regulation of cytokine expression in macrophages and the Langerhans cell-like line XS52 by calcitonin gene-related peptide. J. Leukoc. Biol. 1997. 61: 216-223.
5. Asahina, A., Hosoi, J., Beissert, S., Stratigos, A. and Granstein, R. D., Inhibition of the induction of delayed-type and contact hypersensitivity by calcitonin gene-related peptide. J. Immunol. 1995. 154: 3056-3061.
6. Bhardwaj, R. S., Schwarz, A., Becher, E., Mahnke, K., Aragane, Y., Schwarz, T. and Luger, T. A., Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes. J. Immunol. 1996. 156: 2517-2521.
7. Grabbe, S., Bhardwaj, R. S., Mahnke, K., Simon, M. M., Schwarz, T. and Luger, T. A., alpha-Melanocyte-stimulating hormone induces hapten-specific tolerance in mice. J. Immunol. 1996. 156: 473-478.
8. Niizeki, H., Kurimoto, I. and Streilein, J. W., A substance p agonist acts as an adjuvant to promote hapten-specific skin immunity. J. Invest. Dermatol. 1999. 112: 437-442.
9. Song, I. S., Bunnett, N. W., Olerud, J. E., Harten, B., Steinhoff, M., Brown, J. R., Sung, K. J., Armstrong, C. A. and Ansel, J. C., Substance P induction of murine keratinocyte PAM 212 interleukin 1 production is mediated by the neurokinin 2 receptor (NK-2R). Exp. Dermatol. 2000. 9: 42-52.
10. Miyata, A., Arimura, A., Dahl, R. R., Minamino, N., Uehara, A., Jiang, L., Culler, M. D. and Coy, D. H., Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 1989. 164: 567-574.
11. Vaudry, D., Gonzalez, B. J., Basille, M., Yon, L., Fournier, A. and Vaudry, H., Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol. Rev. 2000. 52: 269-324.
12. Odum, L., Petersen, L. J., Skov, P. S. and Ebskov, L. B., Pituitary adenylate cyclase activating polypeptide (PACAP) is localized in human dermal neurons and causes histamine release from skin mast cells. Inflamm. Res. 1998. 47: 488-492.
13. Torii, H., Yan, Z., Hosoi, J. and Granstein, R. D., Expression of neurotrophic factors and neuropeptide receptors by Langerhans cells and the Langerhans cell-like cell line XS52: further support for a functional relationship between Langerhans cells and epidermal nerves. J. Invest. Dermatol. 1997. 109: 586-591.
14. Delgado, M., Munoz-Elias, E. J., Martinez, C., Gomariz, R. P. and Ganea, D., VIP and PACAP38 modulate cytokine and nitric oxide production in peritoneal macrophages and macrophage cell lines. Ann. N Y Acad. Sci. 1999. 897: 401-414.
15. Delgado, M., Sun, W., Leceta, J. and Ganea, D., VIP and PACAP differentially regulate the costimulatory activity of resting and activated macrophages through the modulation of B7.1 and B7.2 expression. J. Immunol. 1999. 163: 4213-4223.
16. Ferrick, D. A., Schrenzel, M. D., Mulvania, T., Hsieh, B., Ferlin, W. G. and Lepper, H., Differential production of interferon-gamma and interleukin-4 in response to Th1- and Th2-stimulating pathogens by gamma delta T cells in vivo. Nature 1995. 373: 255-257.
17. Pozo, D., Guerrero, J. M. and Calvo, J. R., Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit LPS-stimulated MIP-1alpha production and mRNA expression. Cytokine 2002. 18: 35-42.
18. Wallengren, J., Ekman, R. and Sundler, F., Occurrence and distribution of neuropeptides in the human skin. An immunocytochemical and immunochemical study on normal skin and blister fluid from inflamed skin. Acta Derm. Venereol. 1987. 67: 185-192.
19. Schuler, G. and Steinman, R. M., Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 1985. 161: 526-546.
20. Shimonkevitz, R., Colon, S., Kappler, J. W., Marrack, P. and Grey, H. M., Antigen recognition by H-2-restricted T cells. II. A tryptic ovalbumin peptide that substitutes for processed antigen. J. Immunol. 1984. 133: 2067-2074.
21. Pratt, J. C., van den Brink, M. R., Igras, V. E., Walk, S. F., Ravichandran, K. S. and Burakoff, S. J., Requirement for Shc in TCR-mediated activation of a T cell hybridoma. J. Immunol. 1999. 163: 2586-2591.
22. Wang, B., Amerio, P. and Sauder, D. N., Role of cytokines in epidermal Langerhans cell migration. J. Leukoc. Biol. 1999. 66: 33-39.
23. Lore, K., Sonnerborg, A., Spetz, A. L., Andersson, U. and Andersson, J., Erratum to "Immunocytochemical detection of cytokines and chemokines in Langerhans cells and in vitro derived dendritic cells". J. Immunol. Methods 1998. 218: 173-187.
24. Hosoi, J., Ozawa, H. and Granstein, R. D., beta-Endorphin binding and regulation of cytokine expression in Langerhans cells. Ann. NY Acad. Sci. 1999. 885: 405-413.
25. Chen, G., Kang, K., Kang, S., Rook, A. H., Kubin, M., Voorhees, J. J. and Cooper, K. D., Differential induction of IL-12 p40 and IL-10 mRNA in human Lnagerhans' cells and keratinocytes by in vivo occlusion, vehicle, and all-trans retinoic acid. J. Cutan. Med. Surg. 1996. 1: 74-79.
26. Matsue, H., Cruz, P. D., Jr., Bergstresser, P. R. and Takashima, A., Cytokine expression by epidermal cell subpopulations. J. Invest. Dermatol. 1992. 99: 42S-45S.
27. Cumberbatch, M., Dearman, R. J. and Kimber, I., Stimulation of Langerhans cell migration in mice by tumour necrosis factor alpha and interleukin 1 beta. Adv. Exp. Med. Biol. 1997. 417: 121-124.
28. Ozawa, H., Nakagawa, S., Tagami, H. and Aiba, S., Interleukin-1 beta and granulocyte-macrophage colony-stimulating factor mediate Langerhans cell maturation differently. J. Invest. Dermatol. 1996. 106: 441-445.
29. Panzer, S., Madden, M. and Matsuki, K., Interaction of IL-1 beta, IL-6 and tumour necrosis factor-alpha (TNF-alpha) in human T cells activated by murine antigens. Clin. Exp. Immunol. 1993. 93: 471-478.
30. Wang, B., Zhuang, L., Fujisawa, H., Shinder, G. A., Feliciani C., Shivji, G. M., Suzuki, H., Amerio, P., Toto, P. and Sauder, D. N., Enhanced epidermal Langerhans cell migration in IL-10 knockout mice. J. Immunol. 1999. 162: 277-283.
31. Chatelain, R., Wollenberg, A., Martin, C., Panhans-Gross, A., Bieber, T., Degitz, K. and Heckmann, M., IL-10 inhibits ICAM-1 expression on human Langerhans cells but not on keratinocytes, dermal endothelial cells or fibroblasts. Arch. Dermatol. Res. 1998. 290: 477-482.
32. Yokozeki, H., Takayama, K., Ohki, O., Satoh, T., Umeda, T., Katayama, I. and Nishioka, K., Comparative analysis of CD80 and CD86 on human Langerhans cells: expression and function. Arch. Dermatol. Res. 1998. 290: 547-552.
33. Jonker, M., Ossevoort, Ma and Vierboom, M., Blocking the CD80 and CD86 costimulation molecules: lessons to be learned from animal models. Transplantation 2002. 73: S23-26.
34. Rattis, F. M., Peguet-Navarro, J., Staquet, M. J., Dezutter-Dambuyant, C., Courtellemont, P., Redziniak, G. and Schmitt, D., Expression and function of B7-1 (CD80) and B7-2 (CD86) on human epidermal Langerhans cells. Eur. J. Immunol. 1996. 26: 449-453.
35. Reiser, H. and Schneeberger, E. E., Expression and function of B7-1 and B7-2 in hapten-induced contact sensitivity. Eur. J. Immunol. 1996. 26: 880-885.
36. Nuriya, S., Yagita, H., Okumura, K. and Azuma, M., The differential role of CD86 and CD80 co-stimulatory molecules in the induction and the effector phases of contact hypersensitivity. Int. Immunol. 1996. 8: 917-926.
37. Delgado, M., Munoz-Elias, E. J., Gomariz, R. P. and Ganea, D., VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNgamma synthesis by T cells. J. Neuroimmunol. 1999. 96: 167-181.
38. Delgado, M., Pozo, D., Martinez, C., Leceta, J., Calvo, J. R., Ganea, D. and Gomariz, R. P., Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies. J. Immunol. 1999. 162: 2358-2367.
39. Delgado, M., Munoz-Elias, E. J., Gomariz, R. P. and Ganea, D., Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies. J. Immunol. 1999. 162: 1707-1716.
40. Delgado, M. and Ganea, D., Inhibition of endotoxin-induced macrophage chemokine production by VIP and PACAP in vitro and in vivo. Arch. Physiol. Biochem. 2001. 109: 377-382.
41. Delgado, M., Martinez, C., Pozo, D., Calvo, J. R., Leceta, J., Ganea, D. and Gomariz, R. P., Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6. J. Immunol. 1999. 162: 1200-1205.
42. Kong, L. Y., Maderdrut, J. L., Jeohn, G. H. and Hong, J. S., Reduction of lipopolysaccharide-induced neurotoxicity in mixed cortical neuron/glia cultures by femtomolar concentrations of pituitary adenylate cyclase-activating polypeptide. Neuroscience 1999. 91: 493-500.
43. Martinez, C., Abad, C., Delgado, M., Arranz, A., Juarranz, M. G., Rodriguez-Henche, N., Brabet, P., Leceta, J. and Gomariz, R. P., Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor. Proc. Natl. Acad. Sci. USA 2002. 99: 1053-1058.
44. Goetzl, E. J., Voice, J. K., Shen, S., Dorsam, G., Kong, Y., West, K. M., Morrison, C. F. and Harmar, A. J., Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC(2) receptor for vasoactive intestinal peptide. Proc. Natl. Acad. Sci. USA 2001. 98: 13854-13859.
45. Mulder, H, Jongsma H., Zhang, Y., Gebre-Medhin, S., Sundler, F. and Danielsen, N., Pituitary adenylate cyclase-activating polypeptide and islet amyloid polypeptide in primary sensory neurons: functional implications from plasticity in expression on nerve injury and inflammation. Mol. Neurobiol. 1999. 19: 229-253.
46. Gaytan, F., Martinez-Fuentes, A. J., Garcia-Navarra, F., Vaudry, H. and Aguilar, E., Pituitary adenylate cyclase-activating peptide (PACAP) immunolocalization in lymphoid tissues of the rat. Cell Tissue Res. 1994. 276: 223-227.
47. Lamouche, S., Martineau, D. and Yamaguchi, N., Modulation of adrenal catecholamine release by PACAP in vivo. Am. J. Physiol. 1999. 276: R162-170.
48. Seiffert, K., Hosoi, J., Torii, H., Ozawa, H., Ding, W., Campton, K., Wagner, J. A., and Granstein, R. D., Catecholamines inhibit the antigen-presenting capability of epidermal Langerhans cells. J. Immunol. 2002. 168: 6128-6135.
49. Abad, C., Martinez, C., Leceta, J., Gomariz, R. P. and Delgado, M., Pituitary adenylate cyclase-activating polypeptide inhibits collagen-induced arthritis: an experimental immunomodulatory therapy. J. Immunol. 2001. 167: 3182-3189.
50. Tsutsumi, M., Claus, T. H., Liang, Y., Li, X., Yang, L., Zhu, J., Dela Cruz, F., Peng, X., Chen, H., Yung, S. L., Hamren, S., Livingston, J. N. and Pan, C. Q., A potent and highly selective VPAC2 agonist enhances glucose-induced insulin release and glucose disposal: a potential therapy for type 2 diabetes. Diabetes 2002. 51: 1453-1460.
51. Robberecht, P., Gourlet, P., De Neef, P., Woussen-Colle, M. C., Vandermeers-Piret, M. C., Vandermeers, A. and Christophe, J., Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP(6-38) as a patent antagonist. Eur. J. Biochem. 1992. 207: 239-246.
52. Xu, S., Ariizumi, K., Caceres-Dittmar, G., Edelbaum, O., Hashimoto, K., Bergstresser, P. R. and Takashima, A., Successive generation of antigen-presenting, dendritic cell lines from murine epidermis. J. Immunol. 1995. 154: 2697-2705.
53. Xu, S., Ariizumi, K, Edelbaum, D., Bergstresser, P. R. and Takashima, A., Cytokine-dependent regulation of growth and maturation in murine epidermal dendritic cell lines. Eur. J. Immunol. 1995. 25: 1018-1024.
54. + cells of the T helper 2 subset. J. Immunol. 1990. 145: 2087-2091.
55. Greene, M. I. and Perry, L L., Regulation of the immune response to tumor antigen. VI. Differential specificities of suppressor T cells or their products and effector T cells. J. Immunol. 1978. 121: 2363-2366.
56. Granstein, R. D., Askeri, M., Whitaker, D. and Murphy, G. F., Epidermal cells in activation of suppressor lymphocytes: further characterization. J. Immunol. 1987. 138: 4055-4062.